Iannantuoni, Francesca
Ospedale Infermi di Rimini
3 papers on CoChatORCID 0000-0002-9107-9011
Most cited papers
- Verified
The SGLT2 Inhibitor Empagliflozin Ameliorates the Inflammatory Profile in Type 2 Diabetic Patients and Promotes an Antioxidant Response in Leukocytes
Iannantuoni, F., M. de Marañon, A., Diaz-Morales, N., Falcon, R., Bañuls, C., Abad-Jimenez, Z., Victor, V. M., Hernandez-Mijares, A., & Rovira-Llopis, S. (2019) · Journal of Clinical Medicine
Diabetes Treatment and ManagementAdipokines, Inflammation, and Metabolic Diseases
Cited by 166
- Verified
Cardiovascular benefits of SGLT2 inhibitors and GLP-1 receptor agonists through effects on mitochondrial function and oxidative stress
Luna-Marco, C., Iannantuoni, F., Hermo-Argibay, A., Devos, D., Salazar, J. D., Víctor, V. M., & Rovira-Llopis, S. (2024) · Free Radical Biology and Medicine
Diabetes Treatment and ManagementCardiovascular Function and Risk Factors
Cited by 114
- Verified
The mitochondrial antioxidant SS-31 increases SIRT1 levels and ameliorates inflammation, oxidative stress and leukocyte-endothelium interactions in type 2 diabetes
Escribano-Lopez, I., Diaz-Morales, N., Iannantuoni, F., Lopez-Domenech, S., de Marañon, A. M., Abad-Jimenez, Z., Bañuls, C., Rovira-Llopis, S., Herance, J. R., Rocha, M., et al. (2018) · Scientific Reports
Sirtuins and Resveratrol in MedicineMitochondrial Function and Pathology
Cited by 71
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free